Á lódáil...
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease, whose main molecular trait is the MAPK pathway activation due to KRAS mutation, which is present in 90% of cases. The genetic landscape of KRAS wild type PDAC can be divided into three categories. The first is represented by tumors with an...
Na minha lista:
| Foilsithe in: | J Exp Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594413/ https://ncbi.nlm.nih.gov/pubmed/33115526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01732-6 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|